There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...

GLP-1 agonists, medications commonly used for weight loss and type 2 diabetes, may also help reduce alcohol intake — an ...

Researchers have discovered that tirzepatide and semaglutide impact energy metabolism in distinct ways. New animal research ...

Semaglutide belongs to a group of drugs called GLP-1R agonists and has been shown to effectively reduce food intake and body ...

A new head-to-head study reveals tirzepatide achieves 47% more weight loss than semaglutide in people with obesity but ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

On a weekday morning in Dublin, a group of patients walked into a weight-loss clinic hoping to shed pounds. What they didn’t expect was to also lose their taste for alcohol. A new study has found that ...

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse ...

Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...